A mouse model of non-alcoholic steatohepatitis (NASH) revealed marked caspase-3 activation in hepatocytes, in conjunction with steatohepatitis and increased hepatic triglyceride levels, liver inflammation, and fibrosis. Here, CASP3 is linked to metabolic dysfunction-associated steatohepatitis.